Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 16, Issue 2, Pages 89-110
Publisher
Informa UK Limited
Online
2018-01-09
DOI
10.1080/14787210.2018.1425139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Outbreak of Burkholderia cepacia Complex Infections Associated with Contaminated Liquid Docusate
- (2017) Lucila Marquez et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
- (2017) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients
- (2017) Krisztina M. Papp-Wallace et al. ACS Infectious Diseases
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use
- (2017) P Zarb et al. Eurosurveillance
- Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
- (2016) A. Gomez-Simmonds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii
- (2016) Meritxell García-Quintanilla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient
- (2016) Maria F. Mojica et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections
- (2016) Alan R. Hauser et al. CLINICAL INFECTIOUS DISEASES
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics
- (2016) Fan Liu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
- (2016) Federico Perez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited
- (2016) Burke A. Cunha et al. Expert Review of Anti-Infective Therapy
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
- (2016) Lindsey M. Weiner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-ResistantPseudomonas aeruginosa
- (2016) Stephen B. Vickery et al. PHARMACOTHERAPY
- From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)
- (2016) Yiying Cai et al. PLoS One
- An outbreak of Burkholderia cepacia complex pseudobacteremia associated with intrinsically contaminated commercial 0.5% chlorhexidine solution
- (2015) Suhui Ko et al. AMERICAN JOURNAL OF INFECTION CONTROL
- A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
- (2015) Joel M. Dulhunty et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
- (2015) Cristina García-Salguero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases throughampDMutations in Burkholderia cenocepacia
- (2015) Junghyun Hwang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
- (2015) Sung-Yeon Cho et al. BMC INFECTIOUS DISEASES
- Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel
- (2015) Esteban C. Nannini et al. Brazilian Journal of Infectious Diseases
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2015) Aristine Cheng et al. CRITICAL CARE MEDICINE
- Antibacterial monoclonal antibodies: the next generation?
- (2015) Antonio DiGiandomenico et al. CURRENT OPINION IN MICROBIOLOGY
- Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis
- (2015) Joseph L. Kuti et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Tetracyclines for multidrug-resistant Acinetobacter baumannii infections
- (2015) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology
- (2015) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NLF20: an antimicrobial peptide with therapeutic potential against invasivePseudomonas aeruginosainfection
- (2015) Praveen Papareddy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Avibactam confers susceptibility to a large proportion of ceftazidime-resistantPseudomonas aeruginosaisolates recovered from cystic fibrosis patients
- (2015) Hussein Chalhoub et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Collateral Resistance and Sensitivity Modulate Evolution of High-Level Resistance to Drug Combination Treatment in Staphylococcus aureus
- (2015) Mari Rodriguez de Evgrafov et al. MOLECULAR BIOLOGY AND EVOLUTION
- Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
- (2015) Gerald Murray et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Pseudomonas aeruginosa: Evolution of Antimicrobial Resistance and Implications for Therapy
- (2015) Kate McCarthy SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
- (2015) Anton Peleg et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia
- (2015) María B. Sánchez Frontiers in Microbiology
- Successful outbreak investigation of Burkholderia cepacia complex bacteremia in intensive care patients
- (2014) Yonit Wiener-Well et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
- (2014) Matthieu Boisson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extensively Drug-Resistant Pseudomonas aeruginosa Isolates ContainingblaVIM-2and Elements of Salmonella Genomic Island 2: a New Genetic Resistance Determinant in Northeast Ohio
- (2014) Federico Perez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa
- (2014) Marisa L. Winkler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postoperative endophthalmitis due toBurkholderia cepaciacomplex from contaminated anaesthetic eye drops
- (2014) Prajna Lalitha et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients With Cancer
- (2014) Federico Perez et al. CLINICAL INFECTIOUS DISEASES
- The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences
- (2014) Marie Touchon et al. Genome Biology and Evolution
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
- (2014) L. E. Lopez-Cortes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin
- (2014) Yoann Personne et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
- (2014) M. Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Is Tigecycline a Good Choice in the Treatment of Multidrug-ResistantAcinetobacter baumanniiPneumonia?
- (2014) MS Tasbakan et al. JOURNAL OF CHEMOTHERAPY
- Combination Treatment With Meropenem Plus Levofloxacin Is Synergistic Against Pseudomonas aeruginosa Infection in a Murine Model of Pneumonia
- (2014) Arnold Louie et al. JOURNAL OF INFECTIOUS DISEASES
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colistin: Understanding and Applying Recent Pharmacokinetic Advances
- (2014) Jessica K. Ortwine et al. PHARMACOTHERAPY
- Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis-
- (2014) Ernest A. Azzopardi et al. PLoS One
- The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity
- (2014) Sung-Pin Tseng et al. PLoS One
- POLYCLONAL OUTBREAK OF BLOODSTREAM INFECTIONS CAUSED BY Burkholderia cepacia COMPLEX IN HEMATOLOGY AND BONE MARROW TRANSPLANT OUTPATIENT UNITS
- (2014) Icaro Boszczowski et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Prediction of resistance development against drug combinations by collateral responses to component drugs
- (2014) C. Munck et al. Science Translational Medicine
- Outbreak of Bacteremia Due toBurkholderia contaminansLinked to Intravenous Fentanyl From an Institutional Compounding Pharmacy
- (2014) Rebekah W. Moehring et al. JAMA Internal Medicine
- Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy
- (2013) Maria Beatriz Souza Dias et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
- (2013) Karri A. Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia
- (2013) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
- (2013) Nicola Petrosillo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
- (2013) Haiqing Chu et al. Brazilian Journal of Infectious Diseases
- Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
- (2013) José Garnacho-Montero et al. CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2013) Alexandre P Zavascki et al. Expert Review of Anti-Infective Therapy
- Insights into β-Lactamases fromBurkholderiaSpecies, Two Phylogenetically Related yet Distinct Resistance Determinants
- (2013) Krisztina M. Papp-Wallace et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value
- (2013) Robert K. Flamm et al. JOURNAL OF CHEMOTHERAPY
- Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex
- (2013) E. Righi et al. JOURNAL OF HOSPITAL INFECTION
- Extensively resistant VIM-2-positive Pseudomonas aeruginosa
- (2013) Antoine Andremont et al. LANCET INFECTIOUS DISEASES
- The Culturable Soil Antibiotic Resistome: A Community of Multi-Drug Resistant Bacteria
- (2013) Fiona Walsh et al. PLoS One
- Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities
- (2012) Bartolomé Moyá et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
- (2012) Marilyn N. Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Stenotrophomonas maltophilia from Cystic Fibrosis Patients
- (2012) K. E. N. Milne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosapneumonia
- (2012) So-Youn Park et al. BMC INFECTIOUS DISEASES
- Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage
- (2012) K Tada et al. BONE MARROW TRANSPLANTATION
- Outbreak of Burkholderia cepacia bloodstream infections traced to the use of Ringer lactate solution as multiple-dose vial for catheter flushing, Phnom Penh, Cambodia
- (2012) B. De Smet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosis
- (2012) Matthew N. Hurley et al. EUROPEAN RESPIRATORY JOURNAL
- Modulating immunity as a therapy for bacterial infections
- (2012) Robert E. W. Hancock et al. NATURE REVIEWS MICROBIOLOGY
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
- (2012) Ryan K. Shields et al. PLoS One
- Antimicrobial susceptibility and combination testing of invasiveStenotrophomonas maltophiliaisolates
- (2012) Deirdre Church et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection
- (2011) M. Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms
- (2011) Tom Coenye et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit
- (2011) Chun-Hsing Liao et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
- (2011) G. Samonis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Acinetobacter infection - an emerging threat to human health
- (2011) Paolo Visca et al. IUBMB LIFE
- The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
- (2011) Jung-Jr Ye et al. JOURNAL OF INFECTION
- The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections
- (2011) Seung-Kwan Lim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality
- (2011) Alicia Hernández-Torres et al. MEDICINA CLINICA
- Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa
- (2010) B. Layeux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
- (2010) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
- (2010) P. Drevinek et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Pseudomonas Story
- (2010) Norberto J. Palleroni ENVIRONMENTAL MICROBIOLOGY
- Case-Crossover Study of Burkholderia cepacia Complex Bloodstream Infection Associated with Contaminated Intravenous Bromopride
- (2010) Ianick Souto Martins et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Call of the wild: antibiotic resistance genes in natural environments
- (2010) Heather K. Allen et al. NATURE REVIEWS MICROBIOLOGY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials
- (2009) Mary-Anne W. Aarts et al. CRITICAL CARE MEDICINE
- Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*
- (2009) Daren K. Heyland et al. CRITICAL CARE MEDICINE
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria
- (2009) E. Peeters et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago
- (2009) P. E. Akpaka et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
- In-Vitro Efficacy of Synergistic Antibiotic Combinations in Multidrug Resistant Pseudomonas Aeruginosa Strains
- (2009) Devrim Dundar et al. YONSEI MEDICAL JOURNAL
- In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States
- (2008) C. M. Pillar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia
- (2008) M. Y. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Naturally Occurring Class A ss-Lactamases from the Burkholderia cepacia Complex
- (2008) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Burkholderia cepacia Bacteremia Caused by Contaminated Chlorhexidine in a Hemodialysis Unit
- (2008) M. P. Romero-Gómez et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence
- (2008) Sophia G. Avgeri et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Drug interactions modulate the potential for evolution of resistance
- (2008) J.-B. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started